Legend Biotech (LEGN) Institutional Ownership $39.70 +0.78 (+1.99%) Closing price 03:59 PM EasternExtended Trading$39.62 -0.08 (-0.20%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Legend Biotech (NASDAQ:LEGN)CurrentInstitutional OwnershipPercentage70.89%Number ofInstitutional Buyers(last 12 months)150TotalInstitutional Inflows(last 12 months)$878.54MNumber ofInstitutional Sellers(last 12 months)70TotalInstitutional Outflows(last 12 months)$529.25M Get LEGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Legend Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LEGN Institutional Buying and Selling by Quarter Legend Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/19/2025 GF Fund Management CO. LTD.1,715$56K0.0%N/A0.001% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC136,438$4.44M0.0%+36.1%0.075% 2/17/2025 Woodline Partners LP120,304$3.92M0.0%+10.0%0.066% 2/17/2025 Vestal Point Capital LP475,000$15.46M0.9%+280.0%0.260% 2/17/2025 Vident Advisory LLC17,464$568K0.0%-24.2%0.010% 2/17/2025 Squarepoint Ops LLC127,900$4.16M0.0%+44.2%0.070% 2/17/2025 Twinbeech Capital LP73,168$2.38M0.0%+132.6%0.040% 2/17/2025 Two Sigma Advisers LP327,400$10.65M0.0%+904.3%0.179% 2/17/2025 Two Sigma Investments LP642,452$20.91M0.0%+961.9%0.352% 2/17/2025 Tiger Pacific Capital LP222,000$7.22M1.9%+31.4%0.122% Get the Latest News and Ratings for LEGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Tang Capital Management LLC450,000$14.64M1.0%N/A0.246% 2/17/2025 Tema Etfs LLC11,362$370K0.2%N/A0.006% 2/17/2025 Suvretta Capital Management LLC3,496,234$113.77M3.9%N/A1.914% 2/17/2025 Shell Asset Management Co.2,090$68K0.0%+62.0%0.001% 2/17/2025 Polar Asset Management Partners Inc.24,638$802K0.0%+65.8%0.013% 2/17/2025 Polar Capital Holdings Plc381,873$12.43M0.1%-23.0%0.209% 2/17/2025 Nuveen Asset Management LLC110,586$3.60M0.0%+5.4%0.061% 2/17/2025 Millennium Management LLC255,468$8.31M0.0%-55.2%0.140% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.76,795$2.50M0.0%+8.6%0.042% 2/17/2025 LMR Partners LLP67,200$2.19M0.0%-46.0%0.037% 2/17/2025 Janus Henderson Group PLC2,156,749$70.20M0.0%-1.3%1.181% 2/17/2025 Hudson Bay Capital Management LP202,500$6.59M0.0%N/A0.111% 2/17/2025 Deutsche Bank AG135,067$4.40M0.0%+11.7%0.074% 2/17/2025 Deerfield Management Company L.P. Series C1,551,718$50.49M1.0%N/A0.850% 2/17/2025 Braidwell LP2,977,951$96.90M2.9%+93.2%1.631% 2/17/2025 Bayesian Capital Management LP7,600$247K0.0%N/A0.004% 2/17/2025 Bellevue Group AG167,341$5.45M0.1%-1.1%0.092% 2/17/2025 Bank of America Corp DE710,626$23.12M0.0%+192.2%0.389% 2/17/2025 BNP Paribas Financial Markets243,989$7.94M0.0%N/A0.134% 2/17/2025 Ameriprise Financial Inc.766,440$24.94M0.0%+7.4%0.420% 2/17/2025 Alyeska Investment Group L.P.250,000$8.14M0.0%N/A0.137% 2/17/2025 ArrowMark Colorado Holdings LLC1,177,540$38.32M0.5%+23.5%0.645% 2/14/2025 Boxer Capital Management LLC700,000$22.78M1.9%N/A0.383% 2/14/2025 Hhlr Advisors LTD.5,984,550$194.74M6.7%-9.8%3.277% 2/14/2025 Northern Trust Corp284,678$9.26M0.0%+239.3%0.156% 2/14/2025 Tri Locum Partners LP388,704$12.65M2.6%+7.3%0.213% 2/14/2025 Decheng Capital LLC153,558$5.00M1.1%+41.5%0.084% 2/14/2025 Virtus ETF Advisers LLC9,852$321K0.1%+30.6%0.005% 2/14/2025 Price T Rowe Associates Inc. MD6,808,081$221.54M0.0%-39.0%3.728% 2/14/2025 Hsbc Holdings PLC389,413$12.67M0.0%-1.6%0.213% Important: case study on TGT (Ad)Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!Tap here to catch the TGT case study and learn more2/14/2025 Rock Springs Capital Management LP512,132$16.67M0.6%+0.6%0.280% 2/14/2025 Stifel Financial Corp31,365$1.02M0.0%+70.4%0.017% 2/14/2025 Tower Research Capital LLC TRC 4,480$146K0.0%+355.3%0.002% 2/14/2025 Capital International Inc. CA 581,376$18.92M0.2%+1.9%0.318% 2/14/2025 First Trust Advisors LP20,669$673K0.0%+76.3%0.011% 2/14/2025 Capital International Investors2,161,504$70.34M0.0%-2.8%1.184% 2/14/2025 Capital International Sarl54,333$1.77M0.0%-14.2%0.030% 2/13/2025 Marshall Wace LLP361,562$11.77M0.0%-26.9%0.198% 2/13/2025 Jump Financial LLC150,182$4.89M0.1%+2,108.6%0.082% 2/13/2025 Bridgewater Associates LP161,723$5.26M0.0%-2.6%0.089% 2/13/2025 Guggenheim Capital LLC36,924$1.20M0.0%+8.7%0.020% 2/13/2025 Barclays PLC126,571$4.12M0.0%-21.1%0.069% 2/13/2025 Sterling Capital Management LLC83,871$2.73M0.0%+5.6%0.046% 2/13/2025 CenterBook Partners LP123,791$4.03M0.2%+63.6%0.068% 2/13/2025 Renaissance Technologies LLC908,100$29.55M0.0%+4,917.1%0.497% 2/13/2025 Krane Funds Advisors LLC17,044$555K0.0%-9.2%0.009% 2/13/2025 Legal & General Group Plc299,775$9.76M0.0%-39.3%0.164% 2/13/2025 Invesco Ltd.3,309,971$107.71M0.0%+44.7%1.812% 2/13/2025 FMR LLC13,447,012$437.57M0.0%-26.6%7.363% 2/13/2025 Polymer Capital Management HK LTD28,727$935K0.2%-31.3%0.016% 2/13/2025 Federated Hermes Inc.1,490,300$48.49M0.1%-3.2%0.816% 2/13/2025 Springhill Fund Asset Management HK Co Ltd190,800$6.21M10.1%N/A0.104% 2/13/2025 Quadrant Capital Group LLC3,825$124K0.0%+4,296.6%0.002% 2/13/2025 Russell Investments Group Ltd.244,853$7.97M0.0%-11.1%0.134% 2/13/2025Aviva PLC48,300$1.57M0.0%+3.6%0.026% 2/13/2025 Wells Fargo & Company MN12,236$398K0.0%-18.1%0.007% 2/13/2025 Resona Asset Management Co. Ltd.17,450$568K0.0%N/A0.010% 2/13/2025 Prudential PLC39,566$1.29M0.0%+47.5%0.022% 2/12/2025 Cinctive Capital Management LP30,694$999K0.1%N/A0.017% 2/12/2025 Massachusetts Financial Services Co. MA2,263,556$73.66M0.0%-0.5%1.239% 2/12/2025 Groupama Asset Managment44,907$1.47M0.0%+64.0%0.025% 2/12/2025 Headlands Technologies LLC11,935$388K0.0%+2,023.7%0.007% 2/12/2025 Geode Capital Management LLC519,474$16.81M0.0%+5.0%0.284% 2/12/2025 OLD Mission Capital LLC15,927$518K0.0%-3.0%0.009% 2/12/2025 Franklin Resources Inc.258,988$8.43M0.0%+0.2%0.142% 2/12/2025 Alliancebernstein L.P.1,476,151$48.03M0.0%+12.5%0.808% 2/12/2025 Wellington Management Group LLP2,120,775$69.01M0.0%+4.1%1.161% 2/12/2025 Schroder Investment Management Group194,508$6.37M0.0%+74.7%0.107% 2/12/2025 Pictet Asset Management Holding SA89,669$2.92M0.0%+2.5%0.049% 2/12/2025 NEOS Investment Management LLC11,362$370K0.0%-52.5%0.006% 2/12/2025 JPMorgan Chase & Co.998,016$32.48M0.0%+176.0%0.546% 2/12/2025 Artisan Partners Limited Partnership1,505,562$48.99M0.1%+155.3%0.824% 2/12/2025 Korea Investment CORP21,490$699K0.0%-49.5%0.012% 2/12/2025 IvyRock Asset Management HK Ltd267,100$8.69M3.8%+3,827.9%0.146% 2/11/2025 EntryPoint Capital LLC7,614$248K0.1%N/A0.004% 2/11/2025 Taikang Asset Management Hong Kong Co Ltd100,475$3.27M0.5%+107.9%0.055% 2/11/2025 Fox Run Management L.L.C.12,924$421K0.1%N/A0.007% 2/11/2025 KLP Kapitalforvaltning AS18,400$599K0.0%N/A0.010% 2/11/2025 Sei Investments Co.66,855$2.18M0.0%+29.1%0.037% 2/11/2025 Quantbot Technologies LP11,532$375K0.0%+280.3%0.006% Important: case study on TGT (Ad)Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!Tap here to catch the TGT case study and learn more2/11/2025 Sector Gamma AS48,495$1.58M0.5%+25.1%0.027% 2/11/2025 iA Global Asset Management Inc.76,380$2.49M0.0%N/A0.042% 2/10/2025 Signaturefd LLC1,729$56K0.0%+1,052.7%0.001% 2/10/2025 Skandinaviska Enskilda Banken AB publ 3,100$102K0.0%-74.8%0.002% 2/10/2025 Swiss National Bank166,994$5.43M0.0%+1.1%0.091% 2/10/2025 Connor Clark & Lunn Investment Management Ltd.7,324$238K0.0%+12.9%0.004% 2/7/2025 HighTower Advisors LLC10,079$328K0.0%+75.2%0.006% 2/7/2025 Daiwa Securities Group Inc.8,516$278K0.0%+165.5%0.005% 2/7/2025 Zurcher Kantonalbank Zurich Cantonalbank 40,913$1.33M0.0%-18.6%0.022% 2/7/2025 OFI Invest Asset Management2,435$77K0.0%N/A0.001% (Data available from 1/1/2016 forward) LEGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LEGN shares? During the previous two years, 233 institutional investors and hedge funds held shares of Legend Biotech. The most heavily invested institutionals were FMR LLC ($437.57M), RA Capital Management L.P. ($384.84M), Westfield Capital Management Co. LP ($245.53M), Price T Rowe Associates Inc. MD ($221.54M), Hhlr Advisors LTD. ($194.74M), Capital World Investors ($143.56M), and Adage Capital Partners GP L.L.C. ($114.76M).Learn more on LEGN's institutional investors. What percentage of Legend Biotech stock is owned by institutional investors? 70.89% of Legend Biotech stock is owned by institutional investors. Learn more on LEGN's institutional investor holdings. Which institutional investors have been buying Legend Biotech stock? Of the 204 institutional investors that purchased Legend Biotech stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.42M), Suvretta Capital Management LLC ($3.50M), FMR LLC ($1.96M), Braidwell LP ($1.76M), Deerfield Management Company L.P. Series C ($1.55M), Westfield Capital Management Co. LP ($1.53M), and Wellington Management Group LLP ($1.05M). How much institutional buying is happening at Legend Biotech? Institutional investors have bought a total of 36,018,852 shares in the last 24 months. This purchase volume represents approximately $1.71B in transactions. Which Legend Biotech major shareholders have been selling company stock? Of the 112 institutional investors that sold Legend Biotech stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($6.02M), Price T Rowe Associates Inc. MD ($4.36M), TimesSquare Capital Management LLC ($1.32M), Wellington Management Group LLP ($1.14M), Hhlr Advisors LTD. ($1.11M), Johnson & Johnson ($814.59K), and Farallon Capital Management LLC ($729.01K). How much institutional selling is happening at Legend Biotech? Institutional investors have sold a total of 23,798,671 shares in the last 24 months. This volume of shares sold represents approximately $1.08B in transactions. Related Companies TEVA Major Shareholders SMMT Major Shareholders GMAB Major Shareholders ITCI Major Shareholders VTRS Major Shareholders MRNA Major Shareholders RDY Major Shareholders PCVX Major Shareholders SRPT Major Shareholders QGEN Major Shareholders This page (NASDAQ:LEGN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
